Active vitamin D analogs (e.g., calcitriol, paricalcitol) are used clinically to prevent or treat the SHPT and mineral disorders among ESKD and dialysis patients. However, longer use of active vitamin D analogs revealed hypercalcemia, vascular calcification [1] and cardiovascular adverse effects [2...